22 / 54
Interim Report 2015
二零一五年中期報告
21
Corporate Governance
(Continued)
企業管治
（續）
During the first six months of 2015, it met once on 10 March 2015. At
the meeting, the Committee nominated and recommended re-appointment
of Directors for shareholders’ approval at the AGM. Mr. WU Wai Chung,
Michael had not offered himself for re-election due to his impending retirement in
August 2015. The six Directors re-appointed at the AGM were: Dr. LEE Delman,
Mr. YING Tze Man, Kenneth, Mr. CHAK Hubert, Ms. CHAN Chi Yan, Mr.
CHUNG Wai Kwok, Jimmy, and Mr. LI Fuk Kuen, Wilfred.
Investment Committee
The Group has an Investment Committee to guide the Group’s investments in
financial instruments. Currently, the Committee comprises one NED namely,
Dr. LEE Delman and three INEDs, namely Mr. CHAK Hubert (Chairman of the
Committee), Mr. CHAU Tak Hay and Ms. CHAN Chi Yan. Mr. CHAK replaced
Mr. TSE Kam Keung as the Chairman of the Committee after the re-designation
of Mr. TSE as an ED on 1 July 2015. On 10 March 2015, the Committee met
to review the execution of the investment policy by Management, the portfolio
of the Company’s investment and to consider the proposed changes to the
investment guidelines. On 11 August 2015, the Committee met to discuss the
global economic and investment outlook and review the investment strategy.
Corporate Governance Committee
The Group has a Corporate Governance Committee to ensure and uphold good
corporate functions of the Company and its subsidiaries. The Committee currently
comprises five INEDs, namely Mr. CHUNG Wai Kwok, Jimmy (Chairman of
the Committee), Mr. CHAK Hubert, Mr. CHAU Tak Hay, Ms. CHAN Chi Yan
and Mr. HO Lap Kee, Sunny, J.P. Mr. TSE Kam Keung was a member of the
Committee during the period under review and ceased to be a member upon
his re-designation as an ED on 1 July 2015. The Committee met twice on 10
March 2015 and 11 August 2015 to review the Group’s policies and practices
on corporate governance, the Group’s whistle-blowing policy and procedures
and the relevant compliance disclosures in the 2015 Interim Report.
Directors’ and Auditors’ Attendance at the Annual General Meeting
The Chairman of the Board, Dr. LEE Nai Shee, Harry, S.B.S., J.P., and
Chairmen of the Board Committees, namely Mr. CHUNG Wai Kwok, Jimmy
(Chairman of the Audit Committee and Corporate Governance Committee), Mr.
CHAU Tak Hay (Chairman of the Remuneration Committee) and Mr. HO Lap
Kee, Sunny, J.P. (Chairman of the Nomination Committee), attended the AGM
on 8 May 2015. Mr. TSE Kam Keung (Chairman of the Investment Committee
at that time) was unable to attend due to other business engagement overseas.
Two other Directors, Mr. KIHM Lutz Hans Michael and Dr. LEE Delman were
unable to attend due to other business commitments.
The Company’s external auditor, KPMG, also attended the AGM to confirm
the audited financial statements of the Company and to answer questions from
shareholders.
Directors’ Insurance
The Company has arranged Directors’ and Officers’ liability insurance at the
amount of HK$100 million to indemnify Directors for liabilities in respect of legal
actions arising from its day-to-day business activities.
二零一五年首六個月期間，提名委員會於二零一五年三月十
日召開一次會議。委員會於會上提名及推薦連任董事人選，
並提交股東週年大會徵求股東批准。由於吳偉驄先生即將於
二零一五年八月退任，故不會膺選連任。於股東週年大會膺
選連任的六名董事為：李國本博士、英子文先生、翟廸強先
生、陳紫茵女士、鍾維國先生及李福權先生。
投資委員會
本集團設有投資委員會，專責指導本集團在金融工具方面的
投資。現時，委員會成員包括一名非執行董事李國本博士以
及三名獨立非執行董事翟廸強先生（委員會主席）、周德熙先
生及陳紫茵女士。二零一五年七月一日謝錦強先生調任執行
董事後翟廸強先生接任委員會主席職位。二零一五年三月十
日，委員會舉行會議檢討管理層對投資政策的執行情況及本
公司的投資組合，以及考慮變更投資指引的建議。二零一五
年八月十一日，委員會舉行會議討論全球經濟及投資前景並
檢討投資策略。
企業管治委員會
本集團設有企業管治委員會，專責確保和維持本公司及其附
屬公司的良好企業職能。委員會現時由五名獨立非執行董事
鍾維國先生（委員會主席）、翟廸強先生、周德熙先生、陳紫
茵女士及何立基先生，
J.P.
組成。回顧期內謝錦強先生為委
員會成員，後於二零一五年七月一日調任執行董事時終止。
委員會先後於二零一五年三月十日及二零一五年八月十一日
舉行兩次會議檢討本集團的企業管治政策與常規、本集團的
舉報政策與程序，以及二零一五年中期報告中的相關合規披
露情況。
董事及核數師的股東週年大會出席情況
董事會主席李乃 博士，
S.B.S., J.P.
及董事委員會主席，包
括鍾維國先生（審核委員會及企業管治委員會主席）、周德
熙先生（薪酬委員會主席）及何立基先生，
J.P.
（提名委員會主
席）均有出席本公司於二零一五年五月八日舉行的股東週年
大會。謝錦強先生（時任投資委員會主席）由於身處海外處
理其他事務未能出席會議；而其他兩名董事
KIHM Lutz Hans
Michael
先生及李國本博士因有其他業務需要處理，故未能
出席會議。
本公司的外聘核數師畢馬威會計師事務所亦有出席股東週年
大會，以確認本公司的經審核財務報表及回應股東提問。
董事的保險
本公司已安排董事及高級人員責任保險港幣
100,000,000
元，以彌償董事因本公司日常業務活動所產生的法律訴訟責
任。